CMMB vs HOLX · $22.2M cap vs P/E 32, rev $4.10B
Chemomab Therapeutics Ltd DRC (CMMB) versus Hologic Inc (HOLX) — a side-by-side from cached financials, not a winner call.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
CMMB does not have a complete income-statement cache yet.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
CMMB currently screens at market cap $22.2M. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Not investment advice. Open the CMMB and HOLX stock pages for the full models.
Not investment advice.